The Yogi government is making significant strides to transform Uttar Pradesh (UP) into a leading pharmaceutical hub in India. To attract investments and highlight the state’s industry-friendly policies, the Uttar Pradesh State Industrial Development Authority (UPSIDA), in collaboration with the Confederation of Indian Industry (CII), recently organized a roadshow in Chandigarh. This event showcased the immense potential of UP’s pharmaceutical sector and invited key industry players to explore business opportunities in the state.
Key Takeaways from the Pharma Roadshow
Major Pharma Companies Participate in High-Level Talks
The roadshow witnessed participation from top pharmaceutical companies, including:
- Mankind Pharmaceuticals
- Morepen Laboratories
- Alliance Formulations
- Hanukem Laboratories
- Primus Pharmaceuticals
- Park Pharmaceuticals
During one-on-one discussions, these industry leaders engaged with UP government officials to explore investment opportunities, regulatory support, and infrastructural developments in the state.
Dr. G.N. Singh, Advisor to Chief Minister Yogi Adityanath, emphasized the pro-industry policies adopted by the government to facilitate pharmaceutical businesses. He highlighted the government’s commitment to providing a streamlined approval process, advanced logistics, and a supportive regulatory framework.
UPSIDA’s Invitation to Investors
UPSIDA CEO Mayur Maheshwari positioned UP as a prime destination for industrial investments. He assured that the state government is fully committed to assisting investors at every stage, ensuring ease of doing business.
UP offers:
- Investor-friendly policies
- World-class industrial infrastructure
- Robust logistics support
- A large talent pool for the pharma sector
Maheshwari emphasized that this roadshow is a crucial initiative to boost pharmaceutical investments in UP.
Lalitpur’s Bulk Drug Pharma Park: A Game-Changer
As part of the state’s vision to develop a $1 trillion economy, UP is developing a Bulk Drug Pharma Park in Lalitpur, covering 1,472.33 acres.
This mega project aims to:
- Boost domestic pharma manufacturing
- Reduce dependency on imported raw materials
- Strengthen India’s position as the “Pharmacy of the World”
Why Uttar Pradesh is Emerging as a Pharma Investment Hotspot
With its strategic location, world-class infrastructure, and government-backed incentives, Uttar Pradesh is fast becoming the go-to destination for pharmaceutical companies.
Key Advantages of Investing in UP’s Pharma Sector
✅ Ease of Doing Business – Single-window clearance system for investors
✅ Tax Incentives & Subsidies – Special benefits for pharma startups and manufacturers
✅ Industrial Corridors – Seamless connectivity via highways, rail, and airports
✅ Highly Skilled Workforce – Abundant availability of trained professionals
Conclusion: A Bright Future for Pharma in Uttar Pradesh
The Yogi government’s proactive initiatives are setting the stage for Uttar Pradesh to become a powerhouse in the pharmaceutical sector. With massive investments, policy reforms, and infrastructure development, the state is poised to play a crucial role in India’s pharmaceutical growth story.
For pharma investors, entrepreneurs, and industry leaders, Uttar Pradesh offers unparalleled opportunities. As the state moves closer to becoming India’s next pharma hub, now is the perfect time to invest and grow in UP’s thriving pharma ecosystem.